Abstract Submissions

• To withdraw a submitted abstract or request a change in presenter, please complete a Presenter Change/Withdrawal Request Form. 
  • You will need the abstract title, which can be found in your speaker portal.   
  • Abstracts withdrawn after the meeting program is live on our website may remain visible and searchable.

• The submitting author must be the first (presenting) author. There can only be one first (presenting) author. You may recognize colleagues’ contributions in your presentation. 
• An individual may submit and present only one abstract. 
  • Lab heads or principal investigators are not permitted to submit or present on behalf of multiple lab members. 
  • Featured symposia speakers are not eligible to submit or present an abstract. 
• There is no limit to the number of times an individual may appear as a co-author on abstracts. 
• By submitting an abstract, the author consents to receiving communications about ASHG 2026, including the status of the abstract. The submitter will receive all correspondence regarding the abstract and will be considered the presenter. 
• Co-authors do not receive communication related to the abstract. First (presenting) authors are responsible for coordinating communication with co-authors, must notify all authors of all correspondence relating to submission, and confirm that each co-author has agreed to all information as it was submitted. 
• Submitting authors must attend the Annual Meeting in person with the understanding that ASHG is not making any commitments to host virtual or hybrid content formats and reserves the right, at its sole discretion, to adjust presentation format and style. 
• Submitting authors of accepted abstracts must acknowledge acceptance and pay the ASHG 2026 registration fee. Your abstract may be withdrawn, and your opportunity to present may be forfeited without registration. 
• If substitution of the first (presenting) author becomes necessary, you must inform ASHG by completing the Presenter Change Request Form. Substitution is not allowed without prior written approval. 

• Abstracts should clearly reflect scientific research with experimental results and not be perceived as promotional in nature, i.e., advertising services for a company or product. 
• Duplicate abstracts are not permitted regardless of changes in author order. Abstracts suspected to be duplicates may be rejected during the review process. 

The ASHG Annual Meeting only showcases cutting-edge research that is new to the field and appears in an international forum for the first time. If the findings in this abstract submission have been or will be published elsewhere prior to August 26, 2026, authors should make clear what new information will be presented.

• It is the author’s responsibility to update the submission concerning any acceptances that occur before the submission deadline of August 26. 
• For abstracts that are previously published, authors are strongly encouraged to describe any advancement beyond published work that will be presented. 
• At the time of programming, the Program Committee will independently verify whether there is a publication available with an acceptance date before August 26. Failure to disclose prior publication will result in abstracts being deprioritized for oral presentation in plenary or platform sessions. 

For purposes of this policy, “previously published” means: 

1. Accepted for peer-reviewed publication, or 

2. Accepted for oral presentation at other conferences. 

Material posted on a preprint server is NOT considered previously published.

• All submitters must confirm that any reported human participant research was conducted with participants’ voluntary, informed consent, with approval by an appropriate research ethics committee, and consistent with the principles of research ethics. ASHG endorses the protections embodied in the principles of the Declaration of Helsinki and the Belmont Report, and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46). 
• All submitters must confirm that investigations involving animals reported in the abstract must have been conducted in accordance with the FASEB Statement of Principles for the use of Animals in Research and Education. 
• ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these principles. 

Accepted abstracts will be available in the Online Planner in mid-September. At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, media relations staff, and others. Abstracts will be published as submitted. ASHG does not generally edit abstracts, except for style consistency in titles and first author affiliations. 

Please see our Licensing Agreement/Copyright Policy and suggested style for citing ASHG Meeting abstracts on this webpage. 

ASHG aims to encourage presentation of the latest findings and enable responsible and quality reporting of those findings by press in attendance. Though the press may contact authors prior to the presentation for more information, any resulting articles or other press items cannot be released until the work is presented at the meeting. 

General rules to follow:

• Abstract title and author names: Can be released at any time. 
• Abstract text: Can only be released after the meeting program (with the abstract text) is made public. Linking to the abstract text on the ASHG website is suggested. 
• Findings outlined in the abstract (whether a poster or oral presentation): Can only be released after the presentation has occurred. 

If you have any questions about this, please contact [email protected]. 

Submitting authors must agree to the conditions of the Submission Guidelines and Policies. Failure to meet these conditions may result in abstract withdrawal, and the opportunity to present at the Annual Meeting will be forfeited.

After the August 26 deadline, abstracts will be reviewed by the Program Committee (PC). 

Abstracts are reviewed and programmed as follows:

• Each reviewer scores the abstracts independently using this rubric, without knowledge of the names and institutions of the submitters or the scores given by the other reviewers. 
• In early September, the PC meets to assign abstracts based on each abstract’s cumulative score as well as the impact of the science and the balance of topics for ASHG’s multi-disciplinary audience. 
• The PC reserves the right to decline abstracts that lack scientific content or merit, lack human genetics and genomics research and/or data, or that merely announce the availability of a resource or service and are primarily promotional. 
• Abstract decision notifications will be sent to authors in mid-September.